CB-52

• Description :

  CB-52 is the ligand and neutral antagonist of CB2 cannabinoid receptor[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H315-H319-H335

• Target :

  Cannabinoid Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology

• Assay Protocol :

  https://www.medchemexpress.com/cb-52.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O=C(CCCCCCCCCCOC1=CC(O)=CC=C1CCCCCC)NC2CC2

• Molecular Formula :

  C26H43NO3

• Molecular Weight :

  417.62

• Precautions :

  P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P362+P364-P403+P233-P405-P501

• References & Citations :

  [1]Cascio MG, et al. In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands. Br J Pharmacol. 2006 Oct;149 (4) :431-40.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [869376-90-9]